CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
67 hedge funds and large institutions have $178M invested in Concert Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
29
Reduced
13
Closed
17
Calls
$152K
Puts
–
Net Calls
+$152K
Net Calls Change
+$152K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$37.5M |
| 2 |
SAM
Senzar Asset Management
New York
|
$23.2M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
$10.3M |
| 4 |
Millennium Management
New York
|
$8.41M |
| 5 |
Bank of New York Mellon
New York
|
$3.77M |
